<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Recently, mutations of MPL , the gene coding for the thrombopoetin receptor, were demonstrated in ~5% of cases of primary myelofibrosis (PMF) and in ~1% of all cases of essential thrombocytosis (ET).[1][1],[2][2] They represent gain-of-function mutations that confer constitutive activation of the
Adult, Aged, 80 and over, Male, Tryptophan, Middle Aged, Primary Myelofibrosis, Mutation, Humans, Diseases of the blood and blood-forming organs, Female, RC633-647.5, Receptors, Thrombopoietin, Aged, Thrombocythemia, Essential
Adult, Aged, 80 and over, Male, Tryptophan, Middle Aged, Primary Myelofibrosis, Mutation, Humans, Diseases of the blood and blood-forming organs, Female, RC633-647.5, Receptors, Thrombopoietin, Aged, Thrombocythemia, Essential
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 62 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |